Streetbeat News

Analyst Ratings

WDAY

Morgan Stanley analyst Keith Weiss maintains an Overweight rating on Workday (NASDAQ:WDAY) and raises the price target from $230 to $250.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 11:57 am

CMP

BMO Capital analyst Joel Jackson maintains a Market Perform rating on Compass Minerals Intl (NYSE:CMP) and lowers the price target from $50 to $40.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 11:57 am

WDAY

BMO Capital analyst Daniel Jester maintains an Outperform rating on Workday (NASDAQ:WDAY) and raises the price target from $205 to $240.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 11:56 am

ULTA

Morgan Stanley analyst Simeon Gutman maintains an Equal-Weight rating on Ulta Beauty (NASDAQ:ULTA) and lowers the price target from $535 to $520.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 11:55 am

UDR

Morgan Stanley analyst Adam Kramer maintains an Overweight rating on UDR (NYSE:UDR) and lowers the price target from $49 to $45.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 11:55 am

MU

BMO Capital analyst Ambrish Srivastava maintains an Outperform rating on Micron Technology (NASDAQ:MU) and raises the price target from $67 to $80.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 11:55 am

SPHR

Morgan Stanley analyst Benjamin Swinburne maintains an Equal-Weight rating on Sphere Entertainment (NYSE:SPHR) and lowers the price target from $70 to $26.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 11:54 am

ME

Credit Suisse analyst Tiago Fauth reiterates an Outperform rating on 23andMe Holding (NASDAQ:ME) and maintains a $6 price target.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 11:53 am

SGTX

Morgan Stanley analyst Matthew Harrison maintains an Equal-Weight rating on Sigilon Therapeutics (NASDAQ:SGTX) and lowers the price target from $91 to $7.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 11:53 am

RH

Morgan Stanley analyst Simeon Gutman maintains an Equal-Weight rating on RH (NYSE:RH) and lowers the price target from $275 to $260.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 11:52 am